ID SIAL_HUMAN Reviewed; 317 AA. AC P21815; DT 01-MAY-1991, integrated into UniProtKB/Swiss-Prot. DT 11-JAN-2011, sequence version 4. DT 11-NOV-2015, entry version 128. DE RecName: Full=Bone sialoprotein 2; DE AltName: Full=Bone sialoprotein II; DE Short=BSP II; DE AltName: Full=Cell-binding sialoprotein; DE AltName: Full=Integrin-binding sialoprotein; DE Flags: Precursor; GN Name=IBSP; Synonyms=BNSP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS GLY-213; GLY-219 AND VAL-268. RX PubMed=2404984; RA Fisher L.W., McBride O.W., Termine J.D., Young M.F.; RT "Human bone sialoprotein. Deduced protein sequence and chromosomal RT localization."; RL J. Biol. Chem. 265:2347-2351(1990). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLU-195; GLY-213; RP GLY-219 AND ASP-270. RX PubMed=8406493; DOI=10.1006/geno.1993.1340; RA Kerr J.M., Fisher L.W., Termine J.D., Wang M.G., McBride W., RA Young M.F.; RT "The human bone sialoprotein gene (IBSP): genomic localization and RT characterization."; RL Genomics 17:408-415(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLU-195; GLY-213 AND RP ASP-270. RX PubMed=8061918; DOI=10.1016/0945-053X(94)90027-2; RA Kim R.H., Shapiro H.S., Li J.J., Wrana J.L., Sodek J.; RT "Characterization of the human bone sialoprotein (BSP) gene and its RT promoter sequence."; RL Matrix Biol. 14:31-40(1994). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., RA Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., RA Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., RA Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J., RA Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., RA Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., RA Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., RA Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., RA Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., RA Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., RA Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., RA Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., RA Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., RA Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., RA Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., RA Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., RA Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., RA Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., RA McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., RA Waterston R.H., Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 RT and 4."; RL Nature 434:724-731(2005). RN [5] RP PARTIAL PROTEIN SEQUENCE, AND CHARACTERIZATION. RX PubMed=3597437; RA Fisher L.W., Hawkins G.R., Tuross N., Termine J.D.; RT "Purification and partial characterization of small proteoglycans I RT and II, bone sialoproteins I and II, and osteonectin from the mineral RT compartment of developing human bone."; RL J. Biol. Chem. 262:9702-9708(1987). RN [6] RP PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION AT THR-119; THR-122; THR-227; RP THR-228; THR-229; THR-238 AND THR-239, STRUCTURE OF CARBOHYDRATE, RP VARIANT GLY-213, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=11459848; DOI=10.1074/jbc.M105689200; RA Wuttke M., Muller S., Nitsche D.P., Paulsson M., Hanisch F.G., RA Maurer P.; RT "Structural characterization of human recombinant and bone-derived RT bone sialoprotein. Functional implications for cell attachment and RT hydroxyapatite binding."; RL J. Biol. Chem. 276:36839-36848(2001). RN [7] RP PHOSPHORYLATION AT SER-31, SULFATION AT TYR-313 AND TYR-314, AND RP IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=11669636; DOI=10.1021/bi010887r; RA Zaia J., Boynton R., Heinegard D., Barry F.; RT "Posttranslational modifications to human bone sialoprotein determined RT by mass spectrometry."; RL Biochemistry 40:12983-12991(2001). CC -!- FUNCTION: Binds tightly to hydroxyapatite. Appears to form an CC integral part of the mineralized matrix. Probably important to CC cell-matrix interaction. Promotes Arg-Gly-Asp-dependent cell CC attachment. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- PTM: N-glycosylated; glycans consist of sialylated and core- CC fucosylated bi-, tri- and tetraantennary chains. CC {ECO:0000269|PubMed:11459848}. CC -!- PTM: O-glycosylated at eight sites; mucin-type glycans contain CC Gal, GlcNAc, GalNAc and terminal NeuAc. CC {ECO:0000269|PubMed:11459848}. CC -!- PTM: Sulfated on either Tyr-313 or Tyr-314. CC {ECO:0000269|PubMed:11669636}. CC -!- MISCELLANEOUS: It is possible that the segments of clustered CC carboxyl groups mediate the strong binding to hydroxyapatite. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J05213; AAC95490.1; -; mRNA. DR EMBL; L09558; AAA60549.1; -; Genomic_DNA. DR EMBL; L09554; AAA60549.1; JOINED; Genomic_DNA. DR EMBL; L09555; AAA60549.1; JOINED; Genomic_DNA. DR EMBL; L09556; AAA60549.1; JOINED; Genomic_DNA. DR EMBL; L09557; AAA60549.1; JOINED; Genomic_DNA. DR EMBL; L24759; AAC37560.1; -; Genomic_DNA. DR EMBL; L24757; AAC37560.1; JOINED; Genomic_DNA. DR EMBL; AC093768; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS3624.1; -. DR PIR; A35043; GEHUS. DR RefSeq; NP_004958.2; NM_004967.3. DR UniGene; Hs.518726; -. DR DisProt; DP00332; -. DR ProteinModelPortal; P21815; -. DR STRING; 9606.ENSP00000226284; -. DR PhosphoSite; P21815; -. DR BioMuta; IBSP; -. DR DMDM; 317373545; -. DR PaxDb; P21815; -. DR PRIDE; P21815; -. DR DNASU; 3381; -. DR Ensembl; ENST00000226284; ENSP00000226284; ENSG00000029559. DR GeneID; 3381; -. DR KEGG; hsa:3381; -. DR UCSC; uc003hqx.4; human. DR CTD; 3381; -. DR GeneCards; IBSP; -. DR H-InvDB; HIX0031506; -. DR HGNC; HGNC:5341; IBSP. DR MIM; 147563; gene. DR neXtProt; NX_P21815; -. DR PharmGKB; PA29590; -. DR eggNOG; KOG1181; Eukaryota. DR eggNOG; ENOG4111M3T; LUCA. DR GeneTree; ENSGT00390000002485; -. DR HOGENOM; HOG000234824; -. DR HOVERGEN; HBG007981; -. DR InParanoid; P21815; -. DR KO; K06253; -. DR OMA; AYEDEYS; -. DR OrthoDB; EOG7NW6BX; -. DR PhylomeDB; P21815; -. DR TreeFam; TF338678; -. DR Reactome; R-HSA-216083; Integrin cell surface interactions. DR Reactome; R-HSA-3000178; ECM proteoglycans. DR GeneWiki; Bone_sialoprotein; -. DR GenomeRNAi; 3381; -. DR NextBio; 13366; -. DR PRO; PR:P21815; -. DR Proteomes; UP000005640; Chromosome 4. DR Bgee; P21815; -. DR CleanEx; HS_IBSP; -. DR Genevisible; P21815; HS. DR GO; GO:0031012; C:extracellular matrix; IBA:GO_Central. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; ISS:UniProtKB. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0031988; C:membrane-bounded vesicle; ISS:UniProtKB. DR GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW. DR GO; GO:0007155; P:cell adhesion; ISS:UniProtKB. DR GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB. DR GO; GO:0030198; P:extracellular matrix organization; ISS:UniProtKB. DR GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB. DR InterPro; IPR008412; BSP_II. DR PANTHER; PTHR10345; PTHR10345; 1. DR Pfam; PF05432; BSP_II; 1. PE 1: Evidence at protein level; KW Biomineralization; Cell adhesion; Complete proteome; KW Direct protein sequencing; Glycoprotein; Phosphoprotein; Polymorphism; KW Reference proteome; Secreted; Sialic acid; Signal; Sulfation. FT SIGNAL 1 16 FT CHAIN 17 317 Bone sialoprotein 2. FT /FTId=PRO_0000020330. FT MOTIF 286 288 Cell attachment site. FT COMPBIAS 65 173 Asp/Glu-rich (acidic). FT COMPBIAS 76 83 Poly-Glu. FT COMPBIAS 151 158 Poly-Glu. FT MOD_RES 31 31 Phosphoserine. FT {ECO:0000269|PubMed:11669636}. FT MOD_RES 67 67 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 74 74 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 75 75 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 94 94 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 100 100 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 149 149 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 280 280 Phosphoserine. FT {ECO:0000250|UniProtKB:Q28862}. FT MOD_RES 313 313 Sulfotyrosine. FT {ECO:0000269|PubMed:11669636}. FT MOD_RES 314 314 Sulfotyrosine. FT {ECO:0000269|PubMed:11669636}. FT CARBOHYD 104 104 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 119 119 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT CARBOHYD 122 122 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT CARBOHYD 177 177 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 182 182 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 190 190 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 227 227 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT CARBOHYD 228 228 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT CARBOHYD 229 229 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT CARBOHYD 238 238 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT CARBOHYD 239 239 O-linked (GalNAc...). FT {ECO:0000305|PubMed:11459848}. FT VARIANT 195 195 G -> E (in dbSNP:rs1054627). FT {ECO:0000269|PubMed:8061918, FT ECO:0000269|PubMed:8406493}. FT /FTId=VAR_058014. FT VARIANT 213 213 D -> G (in dbSNP:rs13144371). FT {ECO:0000269|PubMed:11459848, FT ECO:0000269|PubMed:2404984, FT ECO:0000269|PubMed:8061918, FT ECO:0000269|PubMed:8406493}. FT /FTId=VAR_058015. FT VARIANT 219 219 R -> G (in dbSNP:rs17013181). FT {ECO:0000269|PubMed:2404984, FT ECO:0000269|PubMed:8406493}. FT /FTId=VAR_058016. FT VARIANT 256 256 T -> A (in dbSNP:rs17013182). FT /FTId=VAR_056579. FT VARIANT 268 268 A -> V (in dbSNP:rs1054628). FT {ECO:0000269|PubMed:2404984}. FT /FTId=VAR_056580. FT VARIANT 270 270 E -> D (in dbSNP:rs1054629). FT {ECO:0000269|PubMed:8061918, FT ECO:0000269|PubMed:8406493}. FT /FTId=VAR_058017. FT CONFLICT 94 94 S -> L (in Ref. 3; AAC37560). FT {ECO:0000305}. SQ SEQUENCE 317 AA; 35148 MW; 736CB6B8C3716FE7 CRC64; MKTALILLSI LGMACAFSMK NLHRRVKIED SEENGVFKYR PRYYLYKHAY FYPHLKRFPV QGSSDSSEEN GDDSSEEEEE EEETSNEGEN NEESNEDEDS EAENTTLSAT TLGYGEDATP GTGYTGLAAI QLPKKAGDIT NKATKEKESD EEEEEEEEGN ENEESEAEVD ENEQGINGTS TNSTEAENGN GSSGGDNGEE GEEESVTGAN AEDTTETGRQ GKGTSKTTTS PNGGFEPTTP PQVYRTTSPP FGKTTTVEYE GEYEYTGANE YDNGYEIYES ENGEPRGDNY RAYEDEYSYF KGQGYDGYDG QNYYHHQ //